Conveen Optima Urisheaths With Collecting Bags Versus Absorbents
Primary Purpose
Urinary Incontinence
Status
Completed
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Conveen Optima is a urisheath to be used together with a collecting bag for urine
absorbent protection
Sponsored by
About this trial
This is an interventional treatment trial for Urinary Incontinence
Eligibility Criteria
Inclusion Criteria:
- Patient over 18
- Out clinic patient
- Patient using absorbent protection for his urinary incontinence
- Moderate to severe urinary incontinence (1 hour pad test > 10g)
- All kind of stable urinary incontinence
- Patient able to apply himself the device
- Patient able to understand the questions
- Patient having given his informed consent
- Patient whose overall treatment for his urinary incontinence is not modified during the study
Exclusion Criteria:
- Patient having a retracted penis
- Patient having skin problem on the penis
- Patient using urisheaths
- Bedridden patient
- Institutionalized patient
- Patient with indwelling catheter or under intermittent catheterisation
- Patient with fecal incontinence leading to the use of absorbent protection
- Patient suffering of urinary tract infection
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Conveen optima urisheaths
absorbent protections
Arm Description
The patient use their usual absorbent protection as comparator. All brands are allowed.
Outcomes
Primary Outcome Measures
Impact on quality of life
Secondary Outcome Measures
Efficacy (leakages)
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01056666
Brief Title
Conveen Optima Urisheaths With Collecting Bags Versus Absorbents
Official Title
Evaluation de l'Impact Sur la qualité de Vie de l'Utilisation d'un système Collecteur Conveen( étuis pénien Conveen Optima Avec Poches de Recueil Conveen) Chez Des Hommes Souffrant d'Une Incontinence Urinaire modérée ou sévère, Comparativement à Leur Protection Absorbante Habituelle
Study Type
Interventional
2. Study Status
Record Verification Date
April 2007
Overall Recruitment Status
Completed
Study Start Date
June 2007 (undefined)
Primary Completion Date
February 2009 (Actual)
Study Completion Date
March 2009 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Coloplast A/S
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The objective of this investigation is to asses with validated scales, the impact on the quality of life of men suffering of moderate to severe incontinence of the use of Conveen Optima urisheath in comparison with their usual absorbent protection.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urinary Incontinence
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
61 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Conveen optima urisheaths
Arm Type
Experimental
Arm Title
absorbent protections
Arm Type
Placebo Comparator
Arm Description
The patient use their usual absorbent protection as comparator. All brands are allowed.
Intervention Type
Device
Intervention Name(s)
Conveen Optima is a urisheath to be used together with a collecting bag for urine
Intervention Description
Conveen optima urisheath is intended to be used together with a collecting bag for urine and to be changed on a daily basis
Intervention Type
Device
Intervention Name(s)
absorbent protection
Intervention Description
The patient use his usual absorbent protection (same brand), and change it when needed
Primary Outcome Measure Information:
Title
Impact on quality of life
Time Frame
Days 0, 15, 30
Secondary Outcome Measure Information:
Title
Efficacy (leakages)
Time Frame
days 13, 14, 15 and days 28, 29, 30
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient over 18
Out clinic patient
Patient using absorbent protection for his urinary incontinence
Moderate to severe urinary incontinence (1 hour pad test > 10g)
All kind of stable urinary incontinence
Patient able to apply himself the device
Patient able to understand the questions
Patient having given his informed consent
Patient whose overall treatment for his urinary incontinence is not modified during the study
Exclusion Criteria:
Patient having a retracted penis
Patient having skin problem on the penis
Patient using urisheaths
Bedridden patient
Institutionalized patient
Patient with indwelling catheter or under intermittent catheterisation
Patient with fecal incontinence leading to the use of absorbent protection
Patient suffering of urinary tract infection
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pierre Costa, Professor
Organizational Affiliation
Hôpital Caremeau Nimes. France
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Conveen Optima Urisheaths With Collecting Bags Versus Absorbents
We'll reach out to this number within 24 hrs